Literature DB >> 2882520

Superactive octapeptide somatostatin analogs containing tryptophan at position 1.

R Z Cai, T Karashima, J Guoth, B Szoke, D Olsen, A V Schally.   

Abstract

We synthesized a series of octapeptide analogs of somatostatin, containing N-terminal tryptophan or another amino acid followed by the hexapeptide sequences Cys-Phe-D-Trp-Lys-Thr-Cys or Cys-Tyr-D-Trp-Lys-Val-Cys and a C-terminal threoninamide or tryptophanamide. After purification by HPLC, the inhibitory activities of these analogs on the release of growth hormone (somatotropin) in rats were determined in vivo. The eight octapeptides with an N-terminal tryptophan residue were found to have a greater inhibitory effect than somatostatin. The most potent of these analogs, D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, was 94.3 times more active than somatostatin. The other analogs, in order of decreasing potency, were Ac-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, D-Trp(For)-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, Ac-Trp(For)-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2, Ac-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2, D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Trp-NH2, and D-Trp-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2. The growth hormone inhibitory activity of these analogs was from 53.7 to 11.6 times greater than that of somatostatin. The octapeptides containing D- or L-tryptophan at the N-terminus, phenylalanine at position 3, and threonine at position 6 exhibited a greater inhibitory effect on growth hormone release than that of the analogs with tyrosine and valine at positions 3 and 6, respectively. Substitution of D-tryptophan for D-phenylalanine at the N-terminus in the octapeptide containing phenylalanine in the third, threonine in the sixth, and threoninamide in the C-terminal position also increased the growth hormone-release inhibitory activity. Time-course assay showed that D-Trp-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-NH2 (RC-98-I), in a dose of 1 microgram/kg of body weight, inhibited the release of growth hormone for at least 3 hr. In view of their high activity and prolonged duration of action, some of these analogs could be useful clinically.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882520      PMCID: PMC304680          DOI: 10.1073/pnas.84.8.2502

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Hypothalamic regulatory hormones.

Authors:  A V Schally; D H Coy; C A Meyers
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

2.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

3.  A potent cyclic hexapeptide analogue of somatostatin.

Authors:  D F Veber; R M Freidlinger; D S Perlow; W J Paleveda; F W Holly; R G Strachan; R F Nutt; B H Arison; C Homnick; W C Randall; M S Glitzer; R Saperstein; R Hirschmann
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

4.  Synthesis and biological actions of prosomatostatin.

Authors:  C A Meyers; W A Murphy; T W Redding; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

5.  Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.

Authors:  J Rivier; P Brazeau; W Vale; R Guillemin
Journal:  J Med Chem       Date:  1975-02       Impact factor: 7.446

6.  Somatostatin: analogs with selected biological activities.

Authors:  M Brown; J Rivier; W Vale
Journal:  Science       Date:  1977-06-24       Impact factor: 47.728

7.  Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.

Authors:  R Z Cai; B Szoke; R Lu; D Fu; T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.

Authors:  W A Murphy; M L Heiman; V A Lance; I Mezo; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1985-11-15       Impact factor: 3.575

9.  Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.

Authors:  W A Murphy; C A Meyers; D H Coy
Journal:  Endocrinology       Date:  1981-08       Impact factor: 4.736

10.  A super active cyclic hexapeptide analog of somatostatin.

Authors:  D F Veber; R Saperstein; R F Nutt; R M Freidinger; S F Brady; P Curley; D S Perlow; W J Paleveda; C D Colton; A G Zacchei
Journal:  Life Sci       Date:  1984-04-02       Impact factor: 5.037

  10 in total
  2 in total

1.  Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.

Authors:  W A Banks; A V Schally; C M Barrera; M B Fasold; D A Durham; V J Csernus; K Groot; A J Kastin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives.

Authors:  Florian Hohla; Thomas Winder; Richard Greil; Ferenc G Rick; Norman L Block; Andrew V Schally
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.